SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear?
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Cacaito who wrote (14737)9/18/2000 7:56:15 PM
From: Robert K.  Read Replies (1) of 17367
 
Standards are meant to protect, not to harm. There were 3 adverse drug reactions reported in the meningo P3.
All were in the placebo group. Zero reports for bpi.
The drug is safe. First rule, do no harm. There is a lot more to the benefit side of this equation than the risk side. The FDA needs to do its duty to protect the public.
In this case protection is to make this available.
If you cant understand this then IMO you have a problem.
From a statistical point, you are 100% correct. From a moral point you are 100% wrong.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News